Page last updated: 2024-09-03

small cardioactive peptide b and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

small cardioactive peptide b has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies

Compound Research Comparison

Studies
(small cardioactive peptide b)
Trials
(small cardioactive peptide b)
Recent Studies (post-2010)
(small cardioactive peptide b)
Studies
(1-(5-isoquinolinesulfonyl)-2-methylpiperazine)
Trials
(1-(5-isoquinolinesulfonyl)-2-methylpiperazine)
Recent Studies (post-2010) (1-(5-isoquinolinesulfonyl)-2-methylpiperazine)
89033,41241631

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braha, O; Dale, N; Ghirardi, M; Hochner, B; Kandel, ER; Montarolo, PG1

Other Studies

1 other study(ies) available for small cardioactive peptide b and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

ArticleYear
Roles of PKA and PKC in facilitation of evoked and spontaneous transmitter release at depressed and nondepressed synapses in Aplysia sensory neurons.
    Neuron, 1992, Volume: 9, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aplysia; Dose-Response Relationship, Drug; Electrophysiology; Isoquinolines; Neurons, Afferent; Neuropeptides; Neurotransmitter Agents; Phorbol 12,13-Dibutyrate; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Serotonin; Synapses

1992